Lyndra Therapeutics: Funding, Investors & Team (Oct 2026)
Lyndra Therapeutics specializes in creating oral medications that provide prolonged drug release. Their focus lies in developing therapies for central nervous system disorders, ensuring these treatments can be utilized for various therapeutic purposes. By incorporating approved drugs into their formulations, Lyndra Therapeutics aims to enhance medication adherence, improve health outcomes, and potentially reduce healthcare expenses.
Lyndra Therapeutics has raised $101M across 1 funding round on record, the most recent a Series E of $101M announced in Dec 2023.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Lyndra Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2023.
Lyndra Therapeutics Funding Rounds
Lyndra Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Lyndra Therapeutics Funding Compared to Other Biotechnology Startups
Lyndra Therapeutics' latest round of $101M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Lyndra Therapeutics in Biotechnology and Watertown
Companies Similar to Lyndra Therapeutics
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Lyndra Therapeutics Funding FAQs
What does Lyndra Therapeutics do?
Lyndra Therapeutics specializes in creating oral medications that provide prolonged drug release. Their focus lies in developing therapies for central nervous system disorders, ensuring these treatments can be utilized for various therapeutic purposes. By incorporating approved drugs into their formulations, Lyndra Therapeutics aims to enhance medication adherence, improve health outcomes, and potentially reduce healthcare expenses.
How much funding has Lyndra Therapeutics raised?
Lyndra Therapeutics has raised $101M across 1 round on record. The most recent is a Series E of $101M announced in Dec 2023.
When did Lyndra Therapeutics last raise funding?
Lyndra Therapeutics' most recent funding round on record is a Series E of $101M, announced in Dec 2023.
Who founded Lyndra Therapeutics?
FundedIQ lists Colin R Gardner (Founder) at Lyndra Therapeutics.
Where is Lyndra Therapeutics headquartered?
Lyndra Therapeutics is based in Watertown, Massachusetts, United States.
How many employees does Lyndra Therapeutics have?
Lyndra Therapeutics is in the 101-250 employee band.
How does Lyndra Therapeutics' funding compare to other Biotechnology startups?
Lyndra Therapeutics' latest round of $101M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Lyndra Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Lyndra Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.